Search
Apogee Therapeutics Inc
APGEAdd to Watchlist
135.070USD
-0.010-0.01%
Close 09-02 16:00（ET）
10.18BMarket Cap
LossP/E TTM
APGE Analyst Recommendation Trends
In the current month, APGE has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APGE average Analyst price target in the last month is 134.422.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
1
8
8
8
8
8
0
0
1
7
6
6
6
6
0
0
13
4
3
3
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15
19
17
17
16
16
Financial Forecasting
Based on analysts' estimates, APGE EPS is projected to reach -1.173 in FY2026Q3, following reported EPS of -1.138 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.06
-1.10
-1.07
-1.17
-1.29
Actual
-1.03
-1.06
-1.14
--
--
Surprise
+2.39%
+3.42%
-6.28%
--
--
FAQs
How have Apogee Therapeutics IncAPGE's recent earnings per share performed?
The market expectation was USD -1.14, while Apogee Therapeutics IncAPGE's earnings per share (EPS) for the previous quarter was USD -1.06. EPS for the next quarter is expected at USD -1.17.